Sushil Tripathi, Phd Email & Phone Number

Kuopio, Northern Savonia, Finland

As a GLG Council Member consultant, I bring 13 years of experience in clinical research and development to help clients solve some of their toughest business challenges in clinical diagnostics and laboratory operations.

Helsinki, Uusimaa, Finland

- Led and supervised operations & production for high-throughput IVD of infectious diseases- Ensured quality parameters (QC) under GLP and in ISO15189 laboratory- Consistently achieved TAT >97% for samples testing and reporting to the customers- Proposed diagnostic solutions for clinical testing of COVID19, Influenza and RSV- Established new high-throughput automated CE-IVD pipeline for infectious diseases- Performed clinical testing, documentation (SOPs) for FINAS accreditation under GLP- Conducted External Quality Assessment (EQA) for laboratory operations and quality- Monitored customer-centric KPI and laboratory QC for process workflow- Organized scheduled training and orientation of the workflow for >20 lab members- Managed implementation of LEAN 5S methodology to improve efficiency and save annual cost by 15%

• Initiated and managed collaborative projects involving a team of up to 10 members in 3 countries• Trained and supervised over 5 early-stage researchers • Organized and chaired scientific meetings

• Led projects by designing, executing experiments with external collaborations to explore therapeutic targets for cancers (lung adenocarcinoma, gastrointestinal and ovarian)• Worked closely with multidisciplinary team and discovered JAK2-STAT3 pathway as a therapeutic target for gastrointestinal polyposis.

Helsinki

• Produced and purified Lentiviruses/Retroviruses for genetic manipulations• Introduced RNAseq/NGS data generation and analysis pipeline in the research group• Established orthotopic and subcutaneous lung tumors in NSG and syngeneic mouse models• Introduced Immuno-oncology and Immune profiling of mouse lung cancer tissues• Proven AMPK as critical Immunotherapy targets in lung cancer• Designed therapeutic and toxicity studies of small molecules in cancer cells and mouse.• Profiled tumor suppressor kinases in lung and gastrointestinal cancers• Garnered research funding 500,000€ from different funding sources• Reported results in conferences/meetings and international peer-reviewed journals

Trondheim Area, Norway

- Introduced systems biology approach to successfully identify gastrointestinal cancers therapeutic targets.- Pitched a novel research idea and accomplished its scheduled goals with successful collaborations and managed up to 15 researchers across 4 different countries.- Established a Gastrin Knowledge Base for storage and management of biomedical background knowledge for modeling gastrin responses.- Reported results in conferences and international peer-reviewed journals

Chennai Area, India

Title: Role of smooth muscle cells (SMCs) in atherosclerosis- Established isolation and characterisation of primary SMCs from rat.- Performed isolation and maintenance of primary HUVECs

New Delhi Area, India

Title: Bulk Segregants Analysis for identification of DNA markers linked with alkaloid content in Catharanthus roseus

New Delhi Area, India

To study the association between Brain Derived Neurotrophic factor (BDNF) repeat polymorphism with respect to variable drug response (risperidone)